Evidence Hub

Enantioseparation of proton pump inhibitors using multimodal chiral cation exchangers

Labíková M, Pospíšil A, Znamínko O, Lindner W, Bianconi E, Cavaliere G, Sardella R, Carotti A et al.

Analytical and bioanalytical chemistry, 2026

Abstract

The growing demand for enantioselective pharmaceutical analysis has prompted the development of novel chiral stationary phases (CSPs) tailored for high-performance liquid chromatography (HPLC). More recently, particular attention has been paid to multimodal (mixed-mode) stationary phases, which combine several interaction principles and broaden the applicability of the CSP. In this study, multimodal CSPs based on N-(3,5-dinitrobenzoyl)-tyrosine derivatives, featuring both donor-acceptor and ion-exchange/ion-pairing functionalities, were applied for the enantioseparation of omeprazole, pantoprazole, and lansoprazole, widely used proton pump inhibitors. Two in-house-developed CSPs were evaluated under multiple chromatographic modes, using polar-organic (PO), polar-organic-water (POW), and normal-phase (NP) mobile-phase conditions. PO and POW modes were selected as optimal due to their MS compatibility and sustainable solvent composition. The effect of mobile-phase composition, including MeCN/MeOH ratio and acidic/basic additives, on retention and enantioselectivity was systematically studied. The optimized method enabled the direct analysis of omeprazole enantiomers in a commercial tablet formulation using LC-MS. In parallel, molecular dynamics (MD) simulations were employed to investigate the mechanistic basis of chiral recognition at the molecular level. Key interaction energies and conformational behaviors were analyzed, supporting the experimentally observed…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free